To further investigate the role of p53 in ABC transporter expression after metabolic changes, we used two isogenic colon cancer cell lines (p53+/+ and p53-/- HCT116 cells) that differently respond to DCA treatment [7]. This evidence concerns the gene TP53 and colonic neoplasm.